Cargando…
Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: special survey in Japan (long-term, all-case survey)
To evaluate the safety and effectiveness of the long-term administration of diazoxide in patients with hyperinsulinemic hypoglycemia, a post-marketing surveillance study was conducted. Between 2008 and 2015, with a maximum observation period of 7 yr, 384 patients were monitored; 117 (30.5%) experien...
Autores principales: | Fukutomi, Miwa, Shimodera, Minoru, Maeda, Yoshikazu, Iwakura, Mika, Hara, Mitsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073056/ https://www.ncbi.nlm.nih.gov/pubmed/30083030 http://dx.doi.org/10.1297/cpe.27.131 |
Ejemplares similares
-
Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
por: Newman-Lindsay, Shoshana, et al.
Publicado: (2022) -
Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations
por: Flanagan, S E, et al.
Publicado: (2010) -
Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis
por: Chen, Xiaohong, et al.
Publicado: (2021) -
MON-073 Hyperinsulinemic Hypoglycemia Responsive to Diazoxide Due to a Previously Unknown ABCC8 Dominant Mutation
por: Figueredo, Veronica M, et al.
Publicado: (2020) -
Genome-Wide Homozygosity Analysis Reveals HADH Mutations as a Common Cause of Diazoxide-Responsive Hyperinsulinemic-Hypoglycemia in Consanguineous Pedigrees
por: Flanagan, Sarah E., et al.
Publicado: (2011)